Study To Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy Subjects

NCT05701644 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: C1K 150mg
DRUG: C1K 300mg
DRUG: Placebo with the same volume of C1K 300mg
DRUG: C1K 600mg
DRUG: Placebo with the same volume of C1K 600mg
DRUG: C1K 900mg
DRUG: Placebo with the same volume of C1K 900mg
DRUG: C1K 1200mg
DRUG: Placebo with the same volume of C1K 1200mg

Sponsor

Ensol Bioscience